Home > Healthcare > Medical Devices > Therapeutic Devices > Prostate Cancer Treatment Devices Market

Prostate Cancer Treatment Devices Market Share

Report ID: GMI6089
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Prostate Cancer Treatment Devices Market Share

Some of the major market players operating in the prostate cancer treatment devices market are

Intuitive Surgical
Varian Medical Systems
Elekta
EDAP TMS
SonaCare Medical
Medtronic

Major market players are adopting strategic formulations such as forward integration, new product development, geographical expansion, and research collaborations to garner maximum industry share and promote company growth.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

The market size of prostate cancer treatment devices materials was valued at around USD 3.4 billion in 2022 and will reach over USD 9.7 billion by 2032, attributable to the increasing prevalence of prostate cancer, technological advancements, and growing adoption of robotic-assisted surgeries.

The radiation treatment devices segment was valued at over USD 1.4 billion in 2022. Radiation therapy has a curative potential for localized prostate cancer and is particularly effective in early-stage cases where the cancer is confined to the prostate gland.

The U.S. market for prostate cancer treatment devices is anticipated to reach around USD 4.6 billion by 2032, owing to the increasing prevalence of prostate cancer, favourable reimbursement policies, numerous awareness & screening programs, and R&D activities.

Intuitive Surgical, Varian Medical Systems, Elekta, EDAP TMS, SonaCare Medical, and Medtronic among others.